Global prevalence of human intestinal carriage of ESBL-producing <i>E. coli</i> during and after the COVID-19 pandemic.

ABSTRACT:

Background

There is a pressing need for global surveillance of ESBL-producing Escherichia coli due to its health impacts, travel and increased antibiotic use during the COVID-19 pandemic. This systematic review and meta-analysis aimed to summarize evidence investigating the global prevalence of ESBL E. coli.

Methods

Four databases, including Embase, MEDLINE, PubMed and Web of Science, were searched for quantitative studies that reported prevalence data of faecal carriage of ESBL-producing E. coli published between 23 April 2021 and 22 April 2024. Meta-analysis was performed using the inverse variance heterogeneity model.

Results

Of the 25 studies (13 901 unique participants) included for final analysis, the overall pooled prevalence of ESBL E.

SUBMITTER: Ng RWY 

PROVIDER: S-EPMC11759295 | biostudies-literature | 2025 Feb

REPOSITORIES: biostudies-literature